Skip to main content
53°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nextcure Inc
(NQ:
NXTC
)
1.350
+0.060 (+4.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nextcure Inc
< Previous
1
2
3
Next >
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
April 24, 2024
From
NextCure
Via
GlobeNewswire
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
April 08, 2024
Poster presentation highlights strong safety and pharmacokinetic profiles for LNCB74
From
NextCure
Via
GlobeNewswire
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
April 04, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023
March 21, 2024
NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
NextCure
Via
GlobeNewswire
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
March 23, 2024
The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Friday's After-Market Session
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 21, 2024
Via
Benzinga
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
March 21, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
March 05, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
January 18, 2024
From
NextCure
Via
GlobeNewswire
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
December 21, 2023
From
NextCure
Via
GlobeNewswire
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
US Stocks Higher; Initial Jobless Claims Fall To 202,000
December 14, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 14, 2023
Via
Benzinga
NextCure Provides Year-End Clinical Pipeline Updates
December 14, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From
NextCure
Via
GlobeNewswire
NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
November 15, 2023
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)
October 17, 2023
Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting
From
NextCure
Via
GlobeNewswire
NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
September 26, 2023
From
NextCure
Via
GlobeNewswire
A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
September 12, 2023
From
NextCure
Via
GlobeNewswire
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
September 07, 2023
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
September 05, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
NextCure
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
NextCure
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.